Table 2.

Distribution of people with PSC according to prognostic factors.

Prognostic factor	n (%)
ANALI score without gadolinium >2	42 (54.5)
ANALI score with gadolinium >1	37 (48.1)
Liver stiffness >9.6 kPa	38 (49.4)
Amsterdam–Oxford risk score
Low risk	7 (22.6)
Intermediate risk	7 (22.6)
Intermediate–moderate risk	10 (32.3)
Severe risk	7 (22.6)
Revised Mayo risk score	−0.39 (−1.0 to 0.5)

ANALI score with gadolinium was available in 64 (83%) patients, Amsterdam–Oxford risk score in 31 (40.3%) patients, and the revised Mayo score in 66 (85.7%) patients. Values are expressed as number (percentage) except for Revised Mayo risk score which is expressed as median (interquartile range).

PSC, primary sclerosing cholangitis.